FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051256380> ?p ?o ?g. }

• W2051256380 endingPage "1599" @default.
• W2051256380 startingPage "1591" @default.
• W2051256380 abstract "To resolve questions of drug actions, efficacy, and interactions for platelet-modifying agents used clinically, we have compared the relative capacities and mechanisms of aspirin, dipyridamole, sulfinpyrazone, and dazoxiben to prevent arterial thromboembolism in a baboon model. In 136 studies the agents were given twice daily by oral administration both singly and in combination. The antithrombotic efficacy of a given therapy was determined by its capacity to interrupt steady-state platelet utilization induced by thrombogenic arteriovenous cannulae. When given alone, dipyridamole and sulfinpyrazone reduced the rate at which platelets were utilized by thrombus formation in a dose-dependent manner with essentially complete interruption by dipyridamole at 10 mg/kg per d. In contrast, neither aspirin (2-100 mg/kg per d) nor dazoxiben (20-100 mg/kg per d) decreased cannula platelet consumption detectably despite the striking reduction in the capacity of platelets to produce thromboxane B2. However, aspirin, but not dazoxiben, potentiated the antithrombotic effects of dipyridamole and sulfinpyrazone in a dose-dependent fashion without changing the pharmacokinetics for any of the agents. Complete potentiation required aspirin at 20 mg/kg per d to be given with each dose of dipyridamole. Because dazoxiben's blockade of platelet thromboxane A2 production was not associated with antithrombotic potentiation, and because complete potentiation by aspirin required a dose that fully inhibited vascular production of prostaglandin I2 (PGI2), we conclude that aspirin's potentiating effect on dipyridamole is independent of PGI2 production or inhibition of thromboxane A2 formation. In addition, because frequent repeated and synchronous dosing of aspirin was necessary, aspirin's potentiating effects appear to be produced by mechanism(s) unrelated to its potent, irreversible inhibition of platelet cyclooxygenase." @default.
• W2051256380 created "2016-06-24" @default.
• W2051256380 creator A5018260158 @default.
• W2051256380 creator A5034426105 @default.
• W2051256380 creator A5047037554 @default.
• W2051256380 date "1985-05-01" @default.
• W2051256380 modified "2023-09-25" @default.
• W2051256380 title "Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition." @default.
• W2051256380 cites W104407421 @default.
• W2051256380 cites W1540413135 @default.
• W2051256380 cites W1608933197 @default.
• W2051256380 cites W1964431290 @default.
• W2051256380 cites W1973881189 @default.
• W2051256380 cites W1976573800 @default.
• W2051256380 cites W1979776304 @default.
• W2051256380 cites W1986825644 @default.
• W2051256380 cites W2004915032 @default.
• W2051256380 cites W2015911173 @default.
• W2051256380 cites W2017126941 @default.
• W2051256380 cites W2024233324 @default.
• W2051256380 cites W2025702487 @default.
• W2051256380 cites W2032046842 @default.
• W2051256380 cites W2036810827 @default.
• W2051256380 cites W2051051143 @default.
• W2051256380 cites W2055075682 @default.
• W2051256380 cites W2056733286 @default.
• W2051256380 cites W2056905964 @default.
• W2051256380 cites W2057722347 @default.
• W2051256380 cites W2058440665 @default.
• W2051256380 cites W2062107661 @default.
• W2051256380 cites W2063550825 @default.
• W2051256380 cites W2071064801 @default.
• W2051256380 cites W2075932889 @default.
• W2051256380 cites W2079299332 @default.
• W2051256380 cites W2080994996 @default.
• W2051256380 cites W2081365360 @default.
• W2051256380 cites W2086101232 @default.
• W2051256380 cites W2087979042 @default.
• W2051256380 cites W2091619519 @default.
• W2051256380 cites W2095070822 @default.
• W2051256380 cites W2140482107 @default.
• W2051256380 cites W2147290071 @default.
• W2051256380 cites W2155396275 @default.
• W2051256380 cites W2166916835 @default.
• W2051256380 cites W218347484 @default.
• W2051256380 cites W2316166446 @default.
• W2051256380 cites W2323719464 @default.
• W2051256380 cites W2328106705 @default.
• W2051256380 cites W2328870579 @default.
• W2051256380 cites W2329605444 @default.
• W2051256380 cites W2339792503 @default.
• W2051256380 cites W2409203255 @default.
• W2051256380 cites W2409554066 @default.
• W2051256380 cites W2417682230 @default.
• W2051256380 cites W2418123975 @default.
• W2051256380 cites W2443255991 @default.
• W2051256380 cites W2982717623 @default.
• W2051256380 cites W4238847870 @default.
• W2051256380 cites W85630666 @default.
• W2051256380 cites W2026084369 @default.
• W2051256380 doi "https://doi.org/10.1172/jci111865" @default.
• W2051256380 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/425500" @default.
• W2051256380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3923041" @default.
• W2051256380 hasPublicationYear "1985" @default.
• W2051256380 type Work @default.
• W2051256380 sameAs 2051256380 @default.
• W2051256380 citedByCount "121" @default.
• W2051256380 countsByYear W20512563802012 @default.
• W2051256380 countsByYear W20512563802013 @default.
• W2051256380 countsByYear W20512563802014 @default.
• W2051256380 countsByYear W20512563802015 @default.
• W2051256380 countsByYear W20512563802017 @default.
• W2051256380 crossrefType "journal-article" @default.
• W2051256380 hasAuthorship W2051256380A5018260158 @default.
• W2051256380 hasAuthorship W2051256380A5034426105 @default.
• W2051256380 hasAuthorship W2051256380A5047037554 @default.
• W2051256380 hasBestOaLocation W20512563801 @default.
• W2051256380 hasConcept C126322002 @default.
• W2051256380 hasConcept C181199279 @default.
• W2051256380 hasConcept C185592680 @default.
• W2051256380 hasConcept C2776785769 @default.
• W2051256380 hasConcept C2776890861 @default.
• W2051256380 hasConcept C2777015399 @default.
• W2051256380 hasConcept C2777628954 @default.
• W2051256380 hasConcept C2777738910 @default.
• W2051256380 hasConcept C2779689624 @default.
• W2051256380 hasConcept C2781024287 @default.
• W2051256380 hasConcept C2781128415 @default.
• W2051256380 hasConcept C42219234 @default.
• W2051256380 hasConcept C55493867 @default.
• W2051256380 hasConcept C71924100 @default.
• W2051256380 hasConcept C89560881 @default.
• W2051256380 hasConcept C98274493 @default.
• W2051256380 hasConceptScore W2051256380C126322002 @default.
• W2051256380 hasConceptScore W2051256380C181199279 @default.
• W2051256380 hasConceptScore W2051256380C185592680 @default.
• W2051256380 hasConceptScore W2051256380C2776785769 @default.
• W2051256380 hasConceptScore W2051256380C2776890861 @default.

• next